Skip to content
National Cancer Institute
U.S. National Institutes of Health
| www.cancer.gov
In English |
En español
Search
NCI Home
Cancer Topics
Clinical Trials
Cancer Statistics
Research & Funding
News
About NCI
Clinical Trials Search Results
Quick Links
Director's Corner
Dictionary of Cancer Terms
NCI Drug Dictionary
Funding Opportunities
NCI Publications
Advisory Boards and Groups
Science Serving People
Español
Questions about cancer?
1-800-4-CANCER
LiveHelp® online chat
NCI Highlights
High Dose Chemotherapy Prolongs Survival for Leukemia
Prostate Cancer Study Shows No Benefit for Selenium, Vitamin E
Past Highlights
Results:
1 -9 of 9
Show
10
25
50
100
200
results per page
View Search Criteria
|
Help With Results
Sort By:
Phase of Trial
Title
Type of Trial
Status of Trial
Age Range
Sponsor of Trial
Protocol IDs
Version:
Health Professional
Patient
Format:
Short
------
Short
Medium
Long
Custom
1.
Multihance Versus Magnevist in Breast MRI
Phase
Type
Status
Age
Sponsor
Protocol IDs
Phase III
Diagnostic
Active
18 and over
Pharmaceutical / Industry
MH 131
NCT00486473
Last Modified:
2/27/2008
 
First Published:
8/24/2006
2.
Phase II Study of Breast Tumor Viability Using Delayed Dynamic Contrast-Enhanced MRI After Radiofrequency Ablation in Women With Invasive Breast Cancer
Phase
Type
Status
Age
Sponsor
Protocol IDs
Phase II
Diagnostic, Treatment
Active
18 and over
NCI
UMN-2005LS006
UMN-0412M66271, NCT00373152
Last Modified:
1/9/2009
 
First Published:
4/1/2002
3.
Diagnostic Study of Contrast-Enhanced Magnetic Resonance Imaging and Correlative Molecular Studies in Women With Locally Advanced Breast Cancer Who Are Receiving Neoadjuvant Chemotherapy
Phase
Type
Status
Age
Sponsor
Protocol IDs
No phase specified
Diagnostic
Active
18 and over
NCI
CALGB-150007
NCT00033397
Last Modified:
12/22/2008
 
First Published:
8/1/2002
4.
Diagnostic Study of Contrast-Enhanced Breast Magnetic Resonance Imaging for Women With Stage III Breast Cancer Who Are Receiving Neoadjuvant Chemotherapy
Phase
Type
Status
Age
Sponsor
Protocol IDs
No phase specified
Diagnostic
Active
18 and over
NCI
ACRIN-6657
CALGB-150012, NCT00043017
Last Modified:
11/30/2006
 
First Published:
4/23/2003
5.
Diagnostic Study of Fludeoxyglucose F 18 Positron Emission Tomography and Magnetic Resonance Perfusion Imaging to Predict Likelihood of Progression and Potential Benefit of Treatment in Patients With Neurofibromatosis 1 and Plexiform Neurofibromas
Phase
Type
Status
Age
Sponsor
Protocol IDs
No phase specified
Diagnostic
Active
25 and under
Other
CHP-724
CHP-IRB-2001-8-2543, NCT00060008
6.
Dynamic Breast MRI in Assessing Locally Advanced Breast Cancer
Phase
Type
Status
Age
Sponsor
Protocol IDs
No phase specified
Diagnostic, Treatment
Active
Not specified
Other
237-2006
NCT00455273
Last Modified:
1/24/2008
 
First Published:
8/3/2007
7.
Study of Volume Imaging for Breast Assessment NT (VIBRANT-DE) and 3D Fast Spin-Echo Extended Echo-Train Acquisition (3DFSE-XETA) MRI Sequences for the Diagnosis of Breast Cancer in Women
Phase
Type
Status
Age
Sponsor
Protocol IDs
No phase specified
Diagnostic
Active
Over 21
NCI
MSKCC-07091
07-091, NCT00514319
8.
Assessment of Liver Cancer Response to TACE Using MultiHance-Enhanced MRI
Phase
Type
Status
Age
Sponsor
Protocol IDs
No phase specified
Diagnostic, Treatment
Active
18 to 80
Other
J06108
NA_00003943, NCT00539253
9.
Magnetic Resonance Imaging, Spectroscopic Imaging, and Contrast-Enhanced Imaging of the Prostate at 3 Tesla
Phase
Type
Status
Age
Sponsor
Protocol IDs
No phase specified
Diagnostic
Active
21 and over
Other
06-035
NCT00588679
Select All on One Page
NCI Home
|
Images Version
|
Contact Us
|
Policies
|
Accessibility
|
Viewing Files
|
FOIA
|
Site Help
|
Site Map
A Service of the National Cancer Institute